Related references
Note: Only part of the references are listed.Lithium reduces tau phosphorylation but not Aβ or working memory deficits in a transgenic model with both plaques and tangles
Antonella Caccamo et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Abnormal bundling and accumulation of F-actin mediates tau-induced neuronal degeneration in vivo
Tudor A. Fulga et al.
NATURE CELL BIOLOGY (2007)
Multiple-motor based transport and its regulation by Tau
Michael Vershinin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Chronic lithium administration to FTDP-17 tau and GSK-3β overexpressing mice prevents tau hyperphosphorylation and neurofibrillary tangle formation, but pre-formed neurofibrillary tangles do not revert
Tobias Engel et al.
JOURNAL OF NEUROCHEMISTRY (2006)
Cooexpression of FTDP-17 tau and GSK-3β in transgenic mice induce tau polymerization and neurodegeneration
Tobias Engel et al.
NEUROBIOLOGY OF AGING (2006)
Full reversal of Alzheimer's disease-like phenotype in a mouse model with conditional overexpression of glycogen synthase kinase-3
Tobias Engel et al.
JOURNAL OF NEUROSCIENCE (2006)
Tau suppression in a neurodegenerative mouse model improves memory function
K SantaCruz et al.
SCIENCE (2005)
Inhibition of glycogen synthase kinase-3 by lithium correlates with reduced tauopathy and degeneration in vivo
W Noble et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Role of tau protein in both physiological and pathological conditions
J Avila et al.
PHYSIOLOGICAL REVIEWS (2004)
Glycogen synthase kinase 3: a drug target for CNS therapies
RV Bhat et al.
JOURNAL OF NEUROCHEMISTRY (2004)
Lithium-induced increase in human brain grey matter
GJ Moore et al.
LANCET (2000)
Tau protein isoforms, phosphorylation and role in neurodegenerative disorders
L Buée et al.
BRAIN RESEARCH REVIEWS (2000)
Share Paper
